MedTrace Logo

Quality Control of CE-Labelled Phonak Hearing Systems (Study Part: Sonova2015-00)

NCT02754843 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2016-04-28

No results posted yet for this study

Summary

The purpose of this study, which contains a series of successive study parts, is to methodically evaluate Phonak Hearing Systems on hard of hearing participants to grant quality control prior to each product launch.

Conditions

Interventions

DEVICE

Phonak's equivalent newly developped power BTE

DEVICE

Equivalent competitor device

Sponsors & Collaborators

  • Sonova AG

    lead INDUSTRY

Principal Investigators

  • Simone Ebbing, B.Sc. · Sonova AG

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02754843 on ClinicalTrials.gov